BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wei C, Wang B, Peng D, Zhang X, Li Z, Luo L, He Y, Liang H, Du X, Li S, Zhang S, Zhang Z, Han L, Zhang J. Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas. Front Immunol 2022;13:849592. [PMID: 35444654 DOI: 10.3389/fimmu.2022.849592] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Zheng X, Chen L, Liu W, Zhao S, Yan Y, Zhao J, Tian W, Wang Y. CCNE1 is a predictive and immunotherapeutic indicator in various cancers including UCEC: a pan-cancer analysis. Hereditas 2023;160:13. [PMID: 36964635 DOI: 10.1186/s41065-023-00273-0] [Reference Citation Analysis]
2 Liu Q, Gu L, Qiu J, Qian J. Elevated NDC1 expression predicts poor prognosis and correlates with immunity in hepatocellular carcinoma. J Gastrointest Oncol 2023;14:245-64. [PMID: 36915467 DOI: 10.21037/jgo-22-1166] [Reference Citation Analysis]
3 Zhou X, Li C, Chen T, Li W, Wang X, Yang Q. Targeting RNA N6-methyladenosine to synergize with immune checkpoint therapy. Mol Cancer 2023;22:36. [PMID: 36810108 DOI: 10.1186/s12943-023-01746-6] [Reference Citation Analysis]
4 Tűzesi Á, Hallal S, Satgunaseelan L, Buckland ME, Alexander KL. Understanding the Epitranscriptome for Avant-Garde Brain Tumour Diagnostics. Cancers (Basel) 2023;15. [PMID: 36831575 DOI: 10.3390/cancers15041232] [Reference Citation Analysis]
5 Duan J, Zhang Z, Chen Y, Zhao Y, Sun Q, Wang W, Zheng H, Liang D, Cheng J, Yan J, Li ZC. Imaging phenotypes from MRI for the prediction of glioma immune subtypes from RNA sequencing: A multicenter study. Mol Oncol 2023. [PMID: 36688633 DOI: 10.1002/1878-0261.13380] [Reference Citation Analysis]
6 Liang J, Sun J, Zhang W, Wang X, Xu Y, Peng Y, Zhang L, Xiong W, Liu Y, Liu H. Novel Insights into The Roles of N(6)-methyladenosine (m(6)A) Modification and Autophagy in Human Diseases. Int J Biol Sci 2023;19:705-20. [PMID: 36632456 DOI: 10.7150/ijbs.75466] [Reference Citation Analysis]
7 Wang C, Yin Y, Sun Z, Wang Y, Li F, Wang Y, Zhang Z, Chen X. ATAD2 Upregulation Promotes Tumor Growth and Angiogenesis in Endometrial Cancer and Is Associated with Its Immune Infiltration. Dis Markers 2022;2022:2334338. [PMID: 36479043 DOI: 10.1155/2022/2334338] [Reference Citation Analysis]
8 Wang Z, Zhou J, Zhang H, Ge L, Li J, Wang H. RNA m(6) A methylation in cancer. Mol Oncol 2023;17:195-229. [PMID: 36260366 DOI: 10.1002/1878-0261.13326] [Reference Citation Analysis]
9 Kong F, Zhou Y, Lu Y, Ren C, Chen M, Jia R, Chen J, Ma Y. Transcriptome Profiling Revealed the Relationship Between Immune-Related Genes and m6A Modifiers in Polycystic Ovary Syndrome.. [DOI: 10.21203/rs.3.rs-2083076/v1] [Reference Citation Analysis]
10 Wen S, Li F, Tang Y, Dong L, He Y, Deng Y, Tao Z. LncRNA-MIR222HG is a novel regulator of macrophage polarization in allergic rhinitis that functions by targeting the miR146a-5p/TRAF6/NF-κΒ axis.. [DOI: 10.21203/rs.3.rs-1938710/v1] [Reference Citation Analysis]
11 Shen M, Duan C, Xie C, Wang H, Li Z, Li B, Wang T. Identification of key interferon-stimulated genes for indicating the condition of patients with systemic lupus erythematosus. Front Immunol 2022;13:962393. [DOI: 10.3389/fimmu.2022.962393] [Reference Citation Analysis]
12 Ryzhova M, Galstyan S, Telysheva E, Petrova E, Kobyakov G, Khodzhaev A, Maryashev S. Multiple gliomas. Vopr neirokhir 2022;86:66. [DOI: 10.17116/neiro20228606166] [Reference Citation Analysis]